Has Scott Lightfoot, PA received payments from drug or device companies?

Yes. Drug and device makers reported $61,154 in general payments to Scott Lightfoot, PA across 1,035 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Lightfoot, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Lightfoot, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Lightfoot, PA

Medical · Phoenix, AZNPI 1750337192

Payments from drug & device makers

$61,154in general payments, 2019–2025

Across 1,035 payments — averaging $59.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$40K
Novartis$1K
Sanofi$1K
Pfizer$1K
Merck$1K
Gilead$1K
plus $14K from 54 others

What the payments were for

Consulting fees$1,2722%
Speaking & faculty fees$27,28545%
Travel & lodging$8,74614%
Food & beverage$22,44337%
Education$1,4072%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	181	$40,217
Novartis	80	$1,464
Sanofi	30	$1,365
Pfizer	65	$1,338
Merck	54	$1,257
Gilead(2 entities)	22	$1,042
E.r. Squibb & Sons, L.L.C.	55	$1,033
AbbVie	51	$928
Zimvie Inc.	11	$919
Seagen Inc.	29	$866
Astellas Pharma US Inc	30	$818
Amgen	36	$767
Bristol Myers Squibb	47	$741
Genentech USA, Inc.	30	$654
Johnson & Johnson	30	$559
Daiichi Sankyo Inc.	20	$530
Stemline Therapeutics Inc.	8	$406
Lilly USA, LLC	15	$391
GSK	14	$357
Pharmacyclics LLC, An Abbvie Company	14	$345
Puma Biotechnology, Inc.	16	$342
Incyte Corporation	14	$285
Sanofi-aventis U.S. LLC	3	$285
Bayer	14	$240
AVEO Pharmaceuticals, Inc.	8	$238
EMD Serono, Inc.	11	$220
Takeda Pharmaceuticals U.S.A., Inc.	9	$206
Genmab U.S., Inc.	8	$204
Rigel Pharmaceuticals, Inc.	8	$200
Sumitomo Pharma America, Inc.	1	$190
Springworks Therapeutics, Inc.	7	$186
Blueprint Medicines Corporation	8	$185
Tersera Therapeutics LLC	6	$166
Jazz Pharmaceuticals Inc.	7	$159
Exelixis Inc.	6	$149
Ipsen Biopharmaceuticals, Inc	6	$125
Geistlich Pharma, North America, Inc.	1	$123
Array Biopharma Inc	8	$121
Eisai Inc.	5	$113
Karyopharm Therapeutics Inc.	6	$110
Adaptive Biotechnologies Corporation	3	$89
Geron Corporation	3	$86
Regeneron Healthcare Solutions, Inc.	3	$83
Mirati Therapeutics, Inc.	4	$81
Boehringer Ingelheim	3	$77
Taiho Oncology, Inc.	3	$73
ADC Therapeutics America, Inc.	3	$69
Beigene USA, Inc.	3	$59
Deciphera Pharmaceuticals Inc.	3	$59
Coherus Oncology, Inc.	3	$56
Kyowa Kirin, Inc.	2	$47
Azurity Pharmaceuticals, Inc.	2	$45
Servier Pharmaceuticals LLC	2	$45
Morphosys, US Inc.	2	$40
Pharmaessentia USA Corporation	2	$38
AMAG Pharmaceuticals, Inc.	2	$36
Sobi, Inc	2	$35
G1 Therapeutics, Inc.	2	$35
Myovant Sciences Inc.	2	$31
CTI Biopharma Corp.	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TAGRISSO$16,277
ULTOMIRIS$4,730
IMFINZI$3,246
ELITEK$752
Trodelvy$520
OSSEOTITE NT$262
PADCEV$234
Orserdu$231
ORGOVYX$190
Bio-Gide$123
3i T3$118
TALZENNA$105
XTANDI$105
T3$103

How this compares

$61,154 in reported general payments places this provider in the 95th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona →

Medicare billing

Part B allowed, 2024

$7,075

Medicare patients

Services billed

133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	18	$413
Bicalutamide	13	$213
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$147
Methylprednisolone	14	$108
Azithromycin	18	$62
Fluconazole	15	$49
Alprazolam	12	$13

Paid to pharmacies, not to this prescriber.

Other medical in Phoenix

Scott YoungPhoenix$69K
Jennifer KiserPhoenix$53K
Lakeisha ColterPhoenix$48K
Amy IngersollPhoenix$42K
Ty NielsonPhoenix$18K
Brittany SilvermanPhoenix$16K
John RimerPhoenix$15K
Rana AoufePhoenix$14K
Adam SchwartzPhoenix$12K
Rebecca RowenPhoenix$12K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →